-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0599-131115.pdf
June 20, 2013 - populations, interventions, comparators, and outcomes, will
be further developed in the refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0261_07-16-2010.pdf
January 01, 2010 - populations, interventions,
comparators, and outcomes, will be further developed in the refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND-0520-131115.pdf
November 15, 2013 - populations, interventions, comparators, and outcomes, will
be further developed in the refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0405_01-16-2011.pdf
January 01, 2011 - populations, interventions, comparators, and outcomes, will be further
developed in the refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0174_10-20-2009.pdf
January 01, 2009 - populations, interventions, comparators, and
outcomes, will be further developed in the refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0352_09-22-2010.pdf
January 01, 2010 - populations, interventions, comparators, and outcomes, will be further developed in the
refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND-0658-140831.pdf
July 19, 2014 - populations, interventions,
comparators, and outcomes, will be further developed in the refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND-0623-140828.pdf
April 25, 2014 - populations, interventions, comparators, and outcomes, will be further
developed in the refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND-0576-150420.pdf
December 10, 2014 - populations, interventions, comparators, and outcomes, will be further developed in the
refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0411_02-10-2011.pdf
January 01, 2011 - populations, interventions, comparators, and outcomes, will be further developed in the
refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_june_2012.pdf
January 01, 2012 - inclusion are those interventions expected to be within 0–4 years of potential diffusion (e.g., in
phase … Results
The table below lists the 15 topics for which (1) preliminary phase III data for drugs or phase … In September 2011, the company announced plans for its phase III
trial after releasing final 48-week … results from its phase II trial. … Intarcia presents positive ITCA 650 phase 2
study results for type 2 diabetes at EASD.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/safety-vaccines-protocol.pdf
January 30, 2020 - or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 (152174)
15 ("clinical trial" or "clinical trial, phase … i" or "clinical trial, phase ii" or clinical trial,
phase iii or
clinical trial, phase iv or controlled … randomized
controlled trial").pt. or double-blind method/ or clinical trials as topic/ or clinical trials,
phase … i as topic/ or clinical trials, phase ii as topic/ or clinical trials, phase iii as topic/ or
clinical … trials, phase iv as topic/ or controlled clinical trials as topic/ or randomized
controlled trials
-
effectivehealthcare-admin.ahrq.gov/products/colorectal-cancer-hepatic-therapy/abstract
December 01, 2019 - National Cancer Institute’s Cancer Care Outcomes Research and Surveillance Consortium (CANCORS), and a phase
-
effectivehealthcare-admin.ahrq.gov/products/cardiac-defibrillators/abstract
December 01, 2019 - Expected date of project completion: Phase 1 will be completed in September, 2011
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/therapies-for-autism-spectrum-disorder-2-9-2010.pdf
January 01, 2010 - revised the
key questions to clarify the emphasis on examining the correlation of early treatment phase … KQ3: Are there any identifiable changes early in the treatment phase that predict treatment
outcomes … KQ4: What is the evidence that effects measured at the end of the treatment phase predict long
term … criteria developed based on our understanding
of the literature developed during the topic refinement phase … Weekly during the
review phase of the study, the Project Coordinator will report the number of abstracts
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/lysosomal-storage-diseases-therapies_research-protocol.pdf
November 15, 2012 - report, randomized clinical trials,
simple before-after studies, case
During the Topic Refinement phase … There also
were a number of prospective phase I
and II clinical studies that
complemented the RCTs … we made a
decision to compile the RCTs in the
evidence map, supplementing them with
prospective phase … We also sought prospective
phase I or II nonrandomized studies
that included patient subgroups with … If
higher-level studies (RCTs,
prospective phase I and II) were not
available, case series (single-arm
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/autism_research-protocol.pdf
December 09, 2009 - revised the
key questions to clarify the emphasis on examining the correlation of early treatment phase … KQ3: Are there any identifiable changes early in the treatment phase that predict treatment
outcomes … KQ4: What is the evidence that effects measured at the end of the treatment phase predict long
term … criteria developed based on our understanding
of the literature developed during the topic refinement phase … Weekly during the
review phase of the study, the Project Coordinator will report the number of abstracts
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_june_2012.pdf
January 01, 2012 - inclusion
are those interventions expected to be within 0–4 years of potential diffusion (e.g., in phase … Results
The table below lists the nine topics for which (1) preliminary phase III data on drug topics … and
phase II or phase III data on device or procedure topics were available; (2) information was compiled … This study is
an extension of a phase III, clinical trial (CONQUER). … Qnexa phase 3 data published in obesity show
14.4% average weight loss in severely obese patients
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research-protocol.pdf
November 19, 2012 - During the Topic Refinement phase of this project, Key Informants
suggested that a review focused on … Method/ (118498)
21 Single
Blind Method/ (17086)
22 clinical trial/
(476450)
23 clinical trial, phase … i.pt. (12809)
24 clinical trial, phase ii.pt. (20505)
25 clinical trial, phase iii.pt. (7571)
26 clinical … trial, phase iv.pt. (759)
27 controlled clinical trial.pt. (85694)
28 randomized controlled trial.pt
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-1.pdf
June 01, 2022 - Phase 2
randomized placebo-controlled study of lasmiditan
for the acute treatment of migraine in Japanese … treatment of migraine:
pooled efficacy, safety, and tolerability from the
ACHIEVE I and ACHIEVE II phase … pain burden in patients with treatment-
resistant migraine: effects of galcanezumab in the
CONQUER Phase … Ubrogepant for the acute treatment of
migraine: pooled efficacy from ACHIEVE I and
ACHIEVE II phase … Evaluation of injection-site-related adverse events
with galcanezumab: a post hoc analysis of phase